Furthermore, for the first time, the ABCG1 inhibitor Benzamil was introduced in a ccRCC cell line, indicating that ABCG1 may play a crucial role in the etiology and progression of renal cancer. Here, ABCG1 is linked to nonpapillary renal cell carcinoma.